Michèlle Rosenzwajg

Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis

David Saadoun, Michèlle Rosenzwajg, Florence Joly et al. · New England Journal of Medicine · 2011 · 746 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Therapeutic Effects of Human Mesenchymal Stem Cell–derived Microvesicles in Severe Pneumonia in Mice

Antoine Monsel, Yinggang Zhu, Stéphane Gennai et al. · American Journal of Respiratory and Critical Care Medicine · 2015 · 460 citations · Full text

Veterinary Medicine, Cell Biology, Pathology +17

Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial

Agnès Hartemann, G. Bensimon, Christine Payan et al. · The Lancet Diabetes & Endocrinology · 2013 · 422 citations

Medicine, Immunology, Pharmacotherapy +10

Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial

Michèlle Rosenzwajg, Roberta Lorenzon, P. Cacoub et al. · Annals of the Rheumatic Diseases · 2018 · 402 citations · Full text

Life Sciences, Immunology, Autoimmunity +11

Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study

Harry Sokol, Cécilia Landman, Philippe Seksik et al. · Microbiome · 2020 · 364 citations · Full text

Life Sciences, Immunology, Gastroenterology +16